Blended e-learning and certification for medicines development professionals: results of a 7-year collaboration between King's College, London and the GMDP Academy, New York

The field of Medicines Development faces a continuous need for educational evolution to match the interdisciplinary and global nature of the pharmaceutical industry. This paper discusses the outcomes of a 7-year collaboration between King's College London and the Global Medicines Development Pr...

Full description

Saved in:

Bibliographic Details
Published in:	Frontiers in pharmacology Vol. 15; p. 1417036
Main Authors:	Silva, Honorio, Stonier, Peter, Chopra, Pravin, Coots, Jacob, Criscuolo, Domenico, Guptha, Soneil, Jones, Stuart, Kerpel-Fronius, Sandor, Kesselring, Gustavo, Luria, Xavier, Morgan, David, Power, Eddie, Salek, Sam, Silva, Gustavo, Suto, Tamas, Thakker, Kamlesh, Vandenbroucke, Pol
Format:	Journal Article
Language:	English
Published:	Switzerland Frontiers Media S.A 19-06-2024
Subjects:	certification e-learning King’s life-long learning medicines development pharmaceutical medicine Pharmacology medicines development pharmaceutical medicine e-learning life-long learning King’s continuing professional development certification
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The field of Medicines Development faces a continuous need for educational evolution to match the interdisciplinary and global nature of the pharmaceutical industry. This paper discusses the outcomes of a 7-year collaboration between King's College London and the Global Medicines Development Professionals (GMDP) Academy, which aimed to address this need through a blended e-learning program. The collaboration developed a comprehensive curriculum based on the PharmaTrain syllabus, delivered through a combination of asynchronous and synchronous e-learning methods. The program targeted a diverse range of professionals serving in areas related to Medical Affairs. Over seven annual cohorts, 682 participants from eighty-six countries were enrolled in the program. The program's effectiveness was assessed using Kirkpatrick's model, showing elevated levels of satisfaction (over 4.0 on a five-point scale), suggesting significant gains in competence at the cognitive level and leveraged performance. Notably, 70% of responding alumni reported significant improvement in their functions, corroborated by 30% of their supervisors. The further long-term impact of the program on their respective organization has not been established. The GMDP Academy's program has significantly contributed to life-long learning in Medicines Development, addressing educational gaps and fostering interdisciplinary collaboration. Its success highlights the importance of continuous education in keeping pace with the industry's evolving demands and underscores the potential of blended learning in achieving educational objectives in pharmaceutical medicine.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Reviewed by: Stuart Walker, University of Hertfordshire, United Kingdom Kerstin Breithaupt-Grögler, Independent Researcher, Frankfurt, Germany Edited by: Bernd Rosenkranz, Fundisa African Academy of Medicines Development, South Africa
ISSN:	1663-9812 1663-9812
DOI:	10.3389/fphar.2024.1417036